We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

105 hedge funds and large institutions have $94.2M invested in 9 Meters Biopharma in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

33% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 21

15% more capital invested

Capital invested by funds: $81.7M → $94.2M (+$12.5M)

6% more funds holding

Funds holding: 99 → 105 (+6)

18% less call options, than puts

Call options by funds: $3.34M | Put options by funds: $4.1M

Holders
105
Holders Change
+6
Holders Change %
+6.06%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
28
Reduced
21
Closed
11
Calls
$3.34M
Puts
$4.1M
Net Calls
-$757K
Net Calls Change
-$319K

Top Buyers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
+$3.24M
2
Northern Trust
Northern Trust
Illinois
+$1.6M
3
N
Nuveen
North Carolina
+$1.03M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$876K
5
State Street
State Street
Massachusetts
+$597K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.59M
2
Deutsche Bank
Deutsche Bank
Germany
-$2.46M
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.78M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.44M
5
Morgan Stanley
Morgan Stanley
New York
-$1.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
$52K -$499K -21,175 -91%
SSA
52
Schonfeld Strategic Advisors
New York
$51K +$46.3K +1,965 New
AllianceBernstein
53
AllianceBernstein
Tennessee
$49K – – –
Victory Capital Management
54
Victory Capital Management
Texas
$48K -$1.6K -68 -4%
ACP
55
Ashfield Capital Partners
California
$43K – – –
ECM
56
ExodusPoint Capital Management
New York
$42K +$38.4K +1,630 New
PSIWM
57
Paradigm Strategies in Wealth Management
Minnesota
$40K +$23.6K +1,000 +185%
CAPTRUST Financial Advisors
58
CAPTRUST Financial Advisors
North Carolina
$39K -$105K -4,438 -75%
JWCA
59
J.W. Cole Advisors
Florida
$39K +$2.95K +125 +9%
PWM
60
Prentice Wealth Management
New York
$38K +$12.7K +540 +59%
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$38K +$12.9K +549 +59%
ProShare Advisors
62
ProShare Advisors
Maryland
$37K -$31.2K -1,326 -48%
Two Sigma Advisers
63
Two Sigma Advisers
New York
$36K -$1.78M -75,725 -98%
William Blair & Company
64
William Blair & Company
Illinois
$36K – – –
Citigroup
65
Citigroup
New York
$36K +$14.2K +604 +78%
SW
66
SVB Wealth
Massachusetts
$34K +$30.6K +1,300 New
RE
67
RBC Europe
United Kingdom
$32.5K – – –
TSS
68
Two Sigma Securities
New York
$32K +$29.3K +1,242 New
Legal & General Group
69
Legal & General Group
United Kingdom
$29K – – –
SPIA
70
Steward Partners Investment Advisory
New York
$29K – – –
PFS
71
Prospera Financial Services
Texas
$27K – – –
FWM
72
Frontier Wealth Management
Missouri
$26K – – –
HWA
73
Heritage Wealth Advisors
Virginia
$26K – – –
MML Investors Services
74
MML Investors Services
Massachusetts
$26K – – –
T. Rowe Price Associates
75
T. Rowe Price Associates
Maryland
$26K +$1.77K +75 +8%
1 2
3
4 5

NMTR Hedge Fund Activity: Q3 2021 in Review

105 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2021, worth a combined $94.2M — up 15% from $81.7M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new NMTR positions and 11 closed out — a net gain of 7 holders — while 28 added to existing stakes and 21 trimmed.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $3.24M. The largest seller was Millennium Management, cutting an estimated $2.59M.

  • 105 institutional investors held 9 Meters Biopharma (NMTR) as of Q3 2021, up from 99 in Q2 2021.
  • Funds reported $94.2M of 9 Meters Biopharma stock for Q3 2021, up 15% quarter-over-quarter.
  • 18 funds opened new 9 Meters Biopharma positions in Q3 2021 and 11 closed out, a net change of +7 holders.
  • The largest 9 Meters Biopharma buyer in Q3 2021 was Ghost Tree Capital, an estimated $3.24M added.
  • The largest 9 Meters Biopharma seller in Q3 2021 was Millennium Management, an estimated $2.59M sold.

Based on aggregated 13F filings for Q3 2021.